RWS to Showcase Solutions During ISPOR EU
RWS is to take part in ISPOR, which is to take place between 6-9 November in Vienna, Austria.
RWS is to take part in ISPOR, which is to take place between 6-9 November in Vienna, Austria.
Gerresheimer, a leading provider of healthcare solutions and drug delivery systems for pharma, biotech and cosmetics and Merck, Darmstadt, a leading science and technology company, jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain.
With DropControl, Gerresheimer has developed a new dropper insert for modern drugs with low viscosity for ophthalmology, which prevents the drug from flowing out uncontrollably during use.
Novo Nordisk Pharmatech announced today that it has been included among the top 1% of companies assessed for the EcoVadis Sustainability Assessment Report. This is the first time that Novo Nordisk Pharmatech is part of the report.
Gerresheimer, a leading provider of healthcare and beauty solutions and drug delivery systems for pharma, biotech and cosmetics, confirms guidance for its financial year 2022 (FY22) after another quarter of strong and profitable growth. Revenue rose organically by 17.4% in the third quarter, reflecting strong customer demand, leading market positions and the ongoing success of its High-Value Solutions. Adjusted EBITDA grew organically by 13.3%.
The Gx InnoSafe safety syringe is the first syringe with an integrated passive safety system. The function of this solution is to prevent accidental injury to an already used syringe by an unintentional needle stick, because the needle is shielded in a sleeve immediately after use.
The final version of the revised Annex 1 was published on 25 August 2022, some seven years after the revision process started. Join our virtual instructor-led course on 25 October to ensure that your contamination control strategy meets the requirements of EU GMP Volume 4 Annex I.
New Octave® chromatography systems and dedicated SkillPakTM pre-packed columns
This eLearning provides an overview of ICH Q8 Pharmaceutical Development, ICH Q9 Quality Risk Management (QRM) and Q10 Pharmaceutical Quality System (PQS). It summarises the key principles and benefits that accrue with the effective and collective implementation of ICH Q8,9 and 10.
Connecting, educating and inspiring regulatory professionals. RAPS Convergence is your regulatory meeting place to connect and interact with peers, health